TY  - JOUR
AU  - Bukkems, Vera E
AU  - Necsoi, Coca
AU  - Hidalgo Tenorio, Carmen
AU  - Garcia, Coral
AU  - Alba Alejandre, Irene
AU  - Weiss, Fabian
AU  - Lambert, John S
AU  - van Hulzen, Astrid
AU  - Richel, Olivier
AU  - Te Brake, Lindsey H M
AU  - van der Meulen, Eric
AU  - Burger, David
AU  - Konopnicki, Deborah
AU  - Colbers, Angela
PY  - 2022
DO  - 10.1093/cid/ciab1010
UR  - http://hdl.handle.net/10668/19737
T2  - Clinical infectious diseases : an official publication of the Infectious Diseases Society of America
AB  - Tenofovir alafenamide (TAF), a prodrug of tenofovir (TFV), is included in the majority of the recommended first-line antiretroviral regimens for patients living with human immunodeficiency virus (HIV), but there are limited data on TAF use in pregnant...
LA  - en
KW  - HIV
KW  - mother-to-child transmission
KW  - pharmacokinetics
KW  - pregnancy
KW  - tenofovir alafenamide
KW  - Adenine
KW  - Alanine
KW  - Anti-HIV Agents
KW  - Female
KW  - HIV
KW  - HIV Infections
KW  - Humans
KW  - Pregnancy
KW  - Pregnant Women
KW  - Tenofovir
TI  - Tenofovir Alafenamide Plasma Concentrations Are Reduced in Pregnant Women Living With Human Immunodeficiency Virus (HIV): Data From the PANNA Network.
TY  - research article
VL  - 75
ER  -